Rasio utang jangka cendhak marang ekuitas: NeuroSense Therapeutics Ltd. (NRSN)
The NeuroSense Therapeutics (NRSN) price chart reflects the dynamics of a company developing comprehensive ALS therapies to inhibit neuronal decay. The indicator stands at 0.00. However, the business's Israeli origin creates risks of trial disruptions and logistical failures due to local wars. Meanwhile, drug development follows an autonomous path, remaining independent of market inflation or central bank rate fluctuations.
NeuroSense Therapeutics, Ltd. (NRSN) - rincian metrik lan laporan keuangan
- kuotasi lan prakiraan analis:
- indikator kapitalisasi bursa perusahaan:
- statistik nilai buku emiten:
- data liabilitas lan likuiditas perusahaan:
Utang marang Ekuitas NeuroSense Therapeutics|NRSN - Rasio utang jangka dawa marang modal|Utang jangka cendhak marang modal NeuroSense Therapeutics|NRSN - Utang kumulatif perusahaan|Utang marang nilai buku NeuroSense Therapeutics Ltd|NRSN - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan NeuroSense Therapeutics|Likuiditas cepet neurosense-tx.com
- indikator profitabilitas perusahaan lan kelipatan valuasi:
Analisis kabeh metrik perusahaan:NeuroSense Therapeutics Ltd. NRSN
NeuroSense Therapeutics (NRSN) is investing in screening robotics and software data automation, which requires precise liquidity management to cover operating expenses. The current ratio of short-term loans to equity measures the proportion of liabilities with a maturity of over one year relative to equity, determining the risk of cash flow gaps. A decrease in this ratio confirms financial stability, whereas an increase signals an excessive debt load.
Analisis perusahaan pesaing
Utang jangka cendhak marang modal BIIB|NBIX - Kewajiban jangka cendhak marang modal|Regencell Bioscience - Rasio utang jangka cendhak marang ekuitas|Utang jangka cendhak marang modal axsome.com AXSM|ACAD - Utang jangka cendhak marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal XENE (Xenon Pharmaceuticals Inc.)|Viking Pharma (VKTX) - Utang jangka cendhak marang ekuitas|Kewajiban jangka cendhak marang modal Supernus Corp (SUPN)|Utang jangka cendhak marang ekuitas Catalyst Pharmaceuticals|Rasio utang jangka cendhak marang modal DNLI (denalitherapeutics.com)|Utang jangka cendhak marang modal HRMY|BHVN - Kewajiban jangka cendhak marang modal|Amylyx - Rasio utang jangka cendhak marang ekuitas|Utang jangka cendhak marang modal Trevi Corp TRVI|PRAX - Utang jangka cendhak marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal AVXL (anavex.com)|CeriBell (CBLL) - Utang jangka cendhak marang ekuitas|Kewajiban jangka cendhak marang modal Prothena Biosciences (PRTA)|Utang jangka cendhak marang ekuitas Alector Inc.|Annexon Biosciences Inc. (ANNX) - Koefisien utang jangka cendhak marang modal|Utang jangka cendhak marang modal OMER|NGNE - Kewajiban jangka cendhak marang modal|Utang jangka cendhak marang ekuitas AC Immune SA ACIU|VYGR: Rasio utang jangka cendhak marang modal|NMRA - Utang jangka cendhak marang ekuitas|Koefisien utang jangka cendhak marang modal Scilex Holding Company, Inc. SCLX|TVGN: Utang jangka cendhak marang modal|Kewajiban jangka cendhak marang modal Alpha Cognition Inc. (ACOG)|Rasio utang jangka cendhak marang ekuitas CGTX|IKT: Rasio tanggungan utang jangka cendhak marang modal|Rasio utang jangka cendhak marang ekuitas SAVA (Cassava)|Rasio silihan jangka cendhak marang modal ASRT|Utang jangka cendhak marang modal COYA (Coya Therapeutics)|Rasio tanggungan utang jangka cendhak marang modal VTGN|Ovid Rx - Utang jangka cendhak marang modal|Kewajiban jangka cendhak marang modal Acumen Pharmaceuticals Inc.|CervoMed Inc (CRVO) - Utang jangka cendhak marang ekuitas|Alterity Therapeutics Limited - Rasio tanggungan utang jangka cendhak marang modal|CLNN (Clene Inc) - Utang jangka cendhak marang modal|Utang jangka cendhak marang modal PepGen Corp|Utang jangka cendhak marang ekuitas Jupiter Neurosciences (JUNS)|RLMD: Kewajiban jangka cendhak marang ekuitas|Utang jangka cendhak marang modal ANVS (Annovis Bio Corp)|Grace Therapeutics Inc (GRCE) - Kewajiban jangka cendhak marang modal|AIFF: Rasio utang jangka cendhak marang ekuitas|KLTO - Utang jangka cendhak marang modal|RVPH (Reviva Pharmaceuticals Holdings, Inc.) - Rasio utang jangka cendhak marang ekuitas|MTVA: Rasio silihan jangka cendhak marang modal|NRXS (NeurAxis, Inc) - Utang jangka cendhak marang modal|Helius Medical Technologies Inc. (HSDT) - Koefisien utang jangka cendhak marang modal|Utang jangka cendhak marang modal PASG|Rasio utang jangka cendhak marang ekuitas bionomics.com.au NEUP|Utang jangka cendhak marang ekuitas Minerva Neurosciences, Inc. NERV|Koefisien utang jangka cendhak marang modal Athira Pharma Inc (ATHA)|ADXN - Utang jangka cendhak marang ekuitas|ALZN (Alzamend Neuro, Inc.) - Rasio utang jangka cendhak marang modal|cyclerion.com (CYCN) - Utang jangka cendhak marang ekuitas|Protagenic Therapeutics, Inc. - Rasio tanggungan utang jangka cendhak marang modal|Utang jangka cendhak marang ekuitas Pasithea Therapeutics Corp|Cortigent Medical (CRGT) - Koefisien utang jangka cendhak marang modal|Utang jangka cendhak marang ekuitas Avenue Therapeutics, Inc (ATXI)|BrainStorm Cell Therapeutics Inc. - Rasio utang jangka cendhak marang modal|Utang jangka cendhak marang ekuitas Cara Therapeutics, Inc. CARA|CHRO: Rasio utang jangka cendhak marang modal|Eliem - Utang jangka cendhak marang modal|Kewajiban jangka cendhak marang modal Intra-Cellular Therapies|LBPH (Longboard Pharma) - Rasio utang jangka cendhak marang ekuitas|Marinus Pharma (MRNS) - Utang jangka cendhak marang modal|Utang jangka cendhak marang ekuitas NKGen Biotech, Inc.|NRBO: Rasio tanggungan utang jangka cendhak marang modal|Utang jangka cendhak marang ekuitas Sage Therapeutics (SAGE)|SNPX - Kewajiban jangka cendhak marang modal|Utang jangka cendhak marang ekuitas Trevena, Inc TRVN|VIGL: Rasio utang jangka cendhak marang modal|Anew Medical, Inc. - Utang jangka cendhak marang modal|Kewajiban jangka cendhak marang modal cerevel.com